• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Association between age at onset of multimorbidity and incidence of dementia:

byIva OkajandAlex Chan
May 12, 2022
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. Earlier onset and severity of multimorbidity, the presence of more than 2-3 chronic disease conditions, was strongly associated with increased risk of subsequent dementia and death.

Evidence Rating Level: 1 (Excellent)

With an increasing life expectancy for adults in many high income countries, there has been a corresponding increase in the prevalence of major neurocognitive disorders. The presence of multimorbidity is associated with a higher risk of dementia, however, few studies have investigated the longitudinal effects of early onset and severity of multimorbidity on future development of dementia. This prospective cohort study recruited 10,095 participants aged 35 to 55 to examine the association between multimorbidity, age of onset, and subsequent dementia at four to five-year follow-up across a 30-year duration. Multimorbidity was defined as the presence of two or more chronic disease conditions from a predefined list, and the primary and secondary outcomes of this study were all-cause dementia and mortality, respectively. It was found that participants with a younger age of onset of multimorbidity had a greater risk of developing subsequent dementia than same-age peers, as did participants with increased severity, defined as three or more comorbid chronic diseases. Additionally, comorbid Parkinson’s disease and depression were found to have the highest hazard ratios in the development of subsequent dementia. These findings raise interesting implications for early disease prevention, detection and counseling patients about modifiable risk factors in order to prevent major neurocognitive decline.

Click here to read the study in BMJ

Relevant Reading: Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics

In-Depth [Prospective cohort study]: This study included patients from a large prospective cohort, Whitehall II, which recruited adult British participants between the years of 1985-88. Data was linked to UK National Health Service (NHS) electronic health records for 99.9% of patients. Within this population, a list of 13 chronic conditions was selected from previous research on multimorbidity, including coronary heart disease, stroke, heart failure, diabetes, hypertension, cancer, chronic kidney disease, chronic obstructive pulmonary disease, liver disease, depression, mental disorders other than depression, Parkinson’s disease and arthritis. Within this population, death occurred in 904 participants prior to target age (70) and 639 cases of dementia occurred over a median follow-up of 31.7 years. Multimorbidity was present in 6.6% of participants (n=655/9937) at age 55 and 31.7% at age 70 (n=2464/7783), while the most common comorbid conditions were hypertension, coronary artery disease and depression. When compared with people without any chronic conditions, multimorbidity at age 55 was associated with a higher incidence rate (difference 1.56 [95% CI 0.62 to 2.77]) and a hazard ratio of subsequent dementia of 2.44 (1.82 to 3.26). Furthermore, in individuals with a younger age of onset of multimorbidity, there was a higher risk of dementia at ages 60, 65 and 70 when compared with same-age peers (p<0.001 for all). At age 65, onset of multimorbidity before age 55 was associated with 3.86 (1.80 to 6.52) per 1000 person years higher incidence of dementia (hazard ratio 2.46, 1.80 to 2.26) while onset between 60 and 65 was associated with 1.85 (0.64 to 3.39) per 1000 person years higher incidence (1.51, 1.16 to 1.97). Additionally, increased severity of multimorbidity (≥3 chronic diseases) at age 55 had a 5.22 (1.14 to 11.95) per 1000 person years higher incidence of dementia (hazard ratio 4.96, 2.54 to 9.67). At age 70, these analyses demonstrated a 4.49 (2.33 to 7.19) per 1000 person years higher incidence (1.65, 1.25 to 2.18). In terms of associations between dementia and various dyads of chronic diseases, the presence of both Parkinson’s disease and depression were found to have the highest hazard ratio (10.28, 5.94 to 17.79). Parkinson’s disease and mental disorders also demonstrated the highest individual hazard ratios for development of dementia (8.16, 5.68 to 11.73, and 13.51, 6.53 to 27.95, respectively). Finally, in terms of the secondary outcome of this study, multimorbidity at ages 55, 60, 65 and 70 was associated with mortality, particularly at younger ages of onset of multimorbidity (p<0.001).

RELATED REPORTS

Dementia diagnosis underreporting is common and associated with reduced care engagement

Older married couples demonstrate domain-specific cognitive concordance 

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dementiageriatricsneurology
Previous Post

2 Minute Medicine Rewind February 7, 2022

Next Post

Unhealthy alcohol use may be common amongst patients in the emergency department

RelatedReports

Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

August 29, 2026
Neurology

Older married couples demonstrate domain-specific cognitive concordance 

August 28, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
Next Post
Greater prenatal alcohol exposure trajectories linked to impaired growth and neurodevelopment

Unhealthy alcohol use may be common amongst patients in the emergency department

Majority of pediatric medication-related visits to emergency department are preventable

Open-label placebo effective therapy for children with functional abdominal pain or irritable bowel syndrome

Blood type correlates with egg reserve in infertile women

Betibeglogene autotemcel gene therapy effective for β-thalassemia

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Robotic cholecystectomy benefits high-risk and higher-BMI patients but costs more
  • Antibiotics after appendectomy were not associated with reduced postoperative infections
  • Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.